BEDMINSTER, N.J., Sept. 6, 2011 /PRNewswire/ -- Omthera
Pharmaceuticals, Inc., a privately-held emerging specialty
pharmaceuticals company, announced today that Jerry Wisler,
President and Chief Executive Officer, will present at the Rodman
and Renshaw 13th Annual Healthcare Conference, on September 13,
2011 at 2:25pm ET at the Waldorf Astoria Hotel in New York
City.

About Omthera Pharmaceuticals, Inc.

Founded in 2008, Omthera Pharmaceuticals, Inc. is a privately
held, emerging specialty pharmaceuticals company focusing its
efforts on the clinical development of new therapies for
dyslipidemia. Led by a team of experts with exceptional experience
in developing new therapies for lipid disorders, Omthera is
dedicated to developing innovative therapies for the millions of
patients who have elevated triglyceride levels and increased risk
of cardiovascular disease. In March 2011, the Company initiated a
pivotal Phase III clinical trial for its lead product candidate,
Epanova™, an Omega-3 fatty acid compound in development as a
triglyceride-lowering adjunct therapy to diet in patients with very
high triglycerides (greater than or equal to 500 mg/dL). In
August, 2011, Omthera initiated a Phase III trial for Epanova in
patients with high triglycerides (greater than or equal to 200
mg/dL and less than or equal to 500 mg/dL) currently on statin
therapy. For more information, please visit www.omthera.com[1].